Development of a clinical robotic device for diagnosis, rehabilitation and treatm

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$95,958.00
Award Year:
2011
Program:
SBIR
Phase:
Phase I
Contract:
1R43LM011328-01
Award Id:
n/a
Agency Tracking Number:
R43LM011328
Solicitation Year:
2011
Solicitation Topic Code:
NLM
Solicitation Number:
PAR10-279
Small Business Information
11750 BELTSVILLE DR, STE 300, BELTSVILLE, MD, 20705-3194
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
061997029
Principal Investigator:
GAURAVBAJPAI
(240) 790-0620
bajpai@technosci.com
Business Contact:
SANDRASELHA
(240) 790-0620
selhas@technosci.com
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): Anterior Cruciate Ligament (ACL) injury afflicts at least 200,000 young Americans annually. At least, 50 percent of individuals develop Osteoarthritis (OA) in the ten years after the injury and this imposes a substantial burden on the U.S. health care system. The gold standard for treating the ACL-injured individual is unknown, despite the vast array of surgical and treatment options available. No standard, sensitive, and reliable method exists to compare biomechanical effectiveness of current treatments. Moreover, the lack of such instruments leaves clinicians unable to identify the complicated changes in 3D motion patterns and particular contact mechanics that occur with ACL injury, which play an important role inonset and progression of OA. Our new biomechanical assessment platform that integrates computational modeling and 3D measurements of joint function in the clinical setting will shift research and clinical practice paradigms. It will bridge the gap betweenclinical and laboratory methods of assessing joint function, thereby overcoming the disadvantage of each. A symbolic computational approach that generates the full nonlinear model equations in a smooth, explicit form allows application of powerful tools from modern control theory and efficient, real-time implementation. Our integrated experimental and controls framework allows implementation of novel theoretical concepts into the real-time clinical setting that will vertically advance treatment of ACL injury. The developed device could ultimately be used as a tool for evaluation, treatment planning, objective assessment, comparison, and monitoring of the knee after any musculoskeletal injury or treatment. The instrument has high commercial value due to its broad capabilities and applications and can easily be sold or licensed to hospitals or rehabilitation centers. PUBLIC HEALTH RELEVANCE: Anterior Cruciate Ligament (ACL) injury afflicts at least 200,000 young Americans annually. At least, 50 percent of individuals develop Osteoarthritis (OA) in the ten years after the injury and this imposes a substantial burden on the U.S. health care system. The proposed robotic device will use as a clinician tool for evaluation, treatment planning, objective assessment, comparison, and monitoring of the knee after any musculoskeletal injury or treatment significantly lowering patient discomfort and overall cost burden to the system.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government